#biotechnology — Public Fediverse posts

£500m Cambridge life sciences investment as GSK building nears completion

A £500 million investment set to strengthen Cambridge’s position as a global life sciences hub is nearing a…
#EuropeSays #Britain #Europe #EU #GSK #2000DiscoveryDrive #Biotechnology #Cambridge #CambridgeBiomedicalCampus #Cambridgeinvestment #CambridgeSouthrailwaystation #CambridgeshireandPeterborough #laboratoryspace #Lifesciences #PaulBristow #pharmaceuticalresearch #Prologis #UKlifesciences
https://www.europesays.com/britain/120863/

https://www.europesays.com/britain/120863/ £500m Cambridge life sciences investment as GSK building nears completion #2000DiscoveryDrive #Biotechnology #Cambridge #CambridgeBiomedicalCampus #CambridgeInvestment #CambridgeSouthRailwayStation #CambridgeshireAndPeterborough #GSK #LaboratorySpace #LifeSciences #PaulBristow #PharmaceuticalResearch #Prologis #UKLifeSciences

https://www.europesays.com/ie/680258/ EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy program for epilepsy ahead of first-in-human trial #Biotechnology #Brain #CDMO #Éire #Epilepsy #Gene #GeneTherapy #Health #IE #Ireland #Manufacturing #Seizure #therapy #virus

AstraZeneca reports tozorakimab COPD trial results

AstraZeneca reported Phase III OBERON and TITANIA results showing tozorakimab reduced moderate and severe COPD exacerbations across broad…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Biotechnology #COPDtreatment #FDAPriorityReview #IL-33antibody #PhaseIIItrial #respiratorymedicine #tozorakimab
https://www.europesays.com/britain/120279/

https://www.europesays.com/britain/120279/ AstraZeneca reports tozorakimab COPD trial results #AstraZeneca #Biotechnology #COPDTreatment #FDAPriorityReview #IL33Antibody #PhaseIIITrial #RespiratoryMedicine #tozorakimab

This could give so much hope to so many: Scientists invent a gel that creates Alzheimers-treating neurons from other cells

https://www.livescience.com/health/neuroscience/scientists-invent-a-gel-that-creates-neurons-from-other-cells-which-could-help-treat-alzheimers

#biotech #biotechnology #science #biology #microbiology

🔬 Is it time to challenge the single-target mindset in exosome research?

🔗 Engineering Magnetic Beads for Affinity Enrichment of Exosomes. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0170

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#Exosomes #ExtracellularVesicles #Biotechnology #MagneticBeads #Bioengineering #Diagnostics #Nanobiotechnology #Biomarkers #DrugDelivery #PrecisionMedicine

🔬 Is it time to challenge the single-target mindset in exosome research?

🔗 Engineering Magnetic Beads for Affinity Enrichment of Exosomes. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0170

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#Exosomes #ExtracellularVesicles #Biotechnology #MagneticBeads #Bioengineering #Diagnostics #Nanobiotechnology #Biomarkers #DrugDelivery #PrecisionMedicine

🔬 Is it time to challenge the single-target mindset in exosome research?

🔗 Engineering Magnetic Beads for Affinity Enrichment of Exosomes. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0170

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#Exosomes #ExtracellularVesicles #Biotechnology #MagneticBeads #Bioengineering #Diagnostics #Nanobiotechnology #Biomarkers #DrugDelivery #PrecisionMedicine

🔬 Is it time to challenge the single-target mindset in exosome research?

🔗 Engineering Magnetic Beads for Affinity Enrichment of Exosomes. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0170

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#Exosomes #ExtracellularVesicles #Biotechnology #MagneticBeads #Bioengineering #Diagnostics #Nanobiotechnology #Biomarkers #DrugDelivery #PrecisionMedicine

🔬 Is it time to challenge the single-target mindset in exosome research?

🔗 Engineering Magnetic Beads for Affinity Enrichment of Exosomes. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0170

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#Exosomes #ExtracellularVesicles #Biotechnology #MagneticBeads #Bioengineering #Diagnostics #Nanobiotechnology #Biomarkers #DrugDelivery #PrecisionMedicine

🤖 Can artificial intelligence reveal how bacterial strains differ beneath the surface?

🔗 Predicting Strain-Specific Metabolic Capabilities in the Genus Pseudomonas with a Flux-to-AI Approach Reveals Hidden Cell Envelope Properties. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0190

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#Microbiology #ComputationalBiology #SystemsBiology #ArtificialIntelligence #Biotechnology #SyntheticBiology

Stem cells have potent potential for diabetes treatment
#Health #StemCells #Diabetes #MedicalResearch #Insulin #Biotechnology #HealthScience #RegenerativeMedicine #ClinicalTrials #StemCells #Healthcare #Innovation #BetaCells #ScienceNews #Type1Diabetes
https://the-14.com/stem-cells-have-potent-potential-for-diabetes-treatment/

Biology grads struggle in industry? Theory vs practical gap!
Lack hands-on bioinformatics? Bridge it with BioResire.
Join students: https://whatsapp.com/channel/0029Vb5u2Tp77qVTb1D7bu3r

#BiologyGraduates #BioResire #IndustryStruggle #Bioinformatics #PracticalSkills #LifeSciences #BiotechJobs #SkillGap #IndiaBiotech #Biotechnology #ResearchSkills #HandsOnTraining #BioResireStudents #CareerBridge #STEMCareers #JobReady #BioinfoTraining #GradToIndustry #WhatsAppCommunity #LifeScienceJobs

Degree alone not enough for biotech future? Skills rule now!
Bioinformatics & AI demand surges—upgrade with BioResire.
Join WhatsApp community: https://whatsapp.com/channel/0029Vb5u2Tp77qVTb1D7bu3r
WhatsApp: 6301352398 [email protected] #DegreeVsSkills #BioResire #BiotechSkills #Bioinformatics #FutureJobs #LifeSciences #BiotechCareers #IndiaBiotech #SkillGap #Biotechnology #ResearchSkills #AIinBiology #CareerGrowth #STEMSkills #JobReady #BioinformaticsTraining #PharmaCareers #IndustrySkills #BioResireTraining #LifeScienceJob

Culture Media Quick Lab Guide from BioResire!
Basal, Selective (MacConkey), Differential (MacConkey), Enrichment (Selenite F) for bacteria growth.
Internships: [email protected] #CultureMedia #Microbiology #BloodAgar #ChocolateAgar #MacConkeyAgar #SelectiveMedia #DifferentialMedia #EnrichmentMedia #Biotechnology #BioResire #LabMedia #Microbiologist #BacteriaCulture #LifeSciences #Biotech #MicrobiologyLab #LabTechniques #Science #Biology #Internship

Celebrating National Science Day, inspiring innovation, discovery, and research excellence while empowering future scientists to transform society through life sciences.
#NationalScienceDay #ScienceForFuture #LifeSciences #Innovation #ResearchMatters #FutureScientists #STEMEducation #Biotechnology #ScientificDiscovery #BioResire

Spannend das mit den #Bakterien, die Platin aus alten Katalysatoren recyclen

https://www.ardmediathek.de/video/klimazeit/schwankende-windgeschwindigkeiten-und-die-windkraft-oder-klimazeit-vom-20-02-2026/tagesschau24/Y3JpZDovL3RhZ2Vzc2NoYXUuZGUvNzAzMDMwMzQtMGEyNS00OTQxLThiOTktNjlkNDM0NDYxMzgwX2dhbnplU2VuZHVuZw

#klimazeit #klima #ard #örr #farbfernsehen #doku #fernsehen #biotechnologie #biotech #biotechnology #bacteria #recycling #klimawandel #klimaschutz #klimakrise #positiveDinge #PositiveNachrichten #goodNews #recycle #stuttgart #universität #UniStuttgart #UniversitätStuttgart

#Hemp www.linkedin.com/posts/cannap... #SharedFacts about #Biotechnology advanced by #Evolution

#industrialhemp #sora | Codi P...

GSK raises profit outlook on strong vaccine, HIV drug sales—Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs —Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal--http://bit.ly/w28kSd #earnings #gsk #pfizer #hiv #vaccines #celltherapy #astellas #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GSK raises profit outlook on strong vaccine, HIV drug sales—Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs —Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal--http://bit.ly/w28kSd #earnings #gsk #pfizer #hiv #vaccines #celltherapy #astellas #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GSK buying Aiolos for $1.4B to boost asthma pipeline —Bristol Myers Squibb CEO Boerner emphasizes organic pipeline over recent M&A deals— FDA declines to approve Astellas' gastric cancer drug --http://bit.ly/w28kSd #gsk #asthma #mergersandacquisitions #bristolmyerssquibb #fda #gastriccancer #astellas #jpmhc24 #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

After a record run, fewer biotechs are going public-- Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer— 8 medtech trends to watch in 2024 --http://bit.ly/w28kSd #ipos #merck #astellas #pfizer #bladdercancer #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field-- Biopharma’s top 5 IPOs of 2023 so far --Astellas builds case for menopause drug fezolinetant http://bit.ly/w28kSd #abbvie #mergersandacquisitions #immunogen #ipos #menopause #astellas #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff -- Vertex, CRISPR win world’s first approval for CRISPR-edited therapy from UK --BMS gets US approval for ROS1 lung cancer drug Augtyro-- See more on our front page news http://bit.ly/w28kSd #astellas #vertexpharma #crispr #geneediting #bristolmyerssquibb #lungcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer-- BrainStorm eyes FDA meeting to find path for rejected ALS drug after withdrawing application --Amazon will start delivering prescriptions by drone -- See more on our front page news http://bit.ly/w28kSd #seagen #astellas #merck #keytruda #esmo #bladdercancer #als #fda #amazon #drones #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Why a hidden message in Ozempic’s logo represents a big shift in drug branding -- Merck, Seagen, and Astellas get late-stage win in bladder cancer -- Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses -- See more on our front page news http://bit.ly/w28kSd #ozempic #logo #novonordisk #branding #merck #seagen #astellas #bladdercancer #clinicaltrials #eisai #lungcancer #keytruda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Massachusetts' biotech job boom -- Astellas withdraws lawsuit challenging Medicare drug price negotiation plans -- Pfizer ticks off Lyme vaccine milestone -- See more on our front page news http://bit.ly/w28kSd #massachusetts #astellas #medicare #drugpricing #inflationreductionact #lymedisease #vaccines #clinicaltrials #pfizer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Biogen to eliminate 1,000 jobs in further cost cuts -- Cognizant, Gilead extend service agreement worth $800M -- Astellas notches another protein degrader pact with $21M upfront for PeptiDream -- See more on our front page news http://bit.ly/w28kSd #biogen #layoffs #gileadsciences #astellas #proteindegradation #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board? —FDA advisers narrowly vote in favor of Sarepta's DMD gene therapy —Astellas' menopause drug scores FDA approval, after regulatory setback -- See more on our front page news http://bit.ly/w28kSd #pfizer #seagen #antitrust #mergersandacquisitions #fda #hotflashes #genetherapy #menopause #astellas #dmd #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Astellas to acquire eye drug developer Iveric Bio for $5.9B —With negative FDA panel vote, AstraZeneca's Lynparza looks set for narrow nod in prostate cancer—Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify -- See more on our front page news http://bit.ly/w28kSd #astellas #mergersandacquisitions #eyehealth #fda #prostatecancer #astrazeneca #abilify #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

FDA approves Keytruda/Padcev combo in advanced urothelial cancer — Record growth in U.S. life sciences real estate footprint — Diabesity drugs and their free ‘contract sales force’ -- See more on our front page news http://bit.ly/w28kSd #fda #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi — Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test— Boston Scientific, Medtronic expected to quickly capture new atrial fibrillation market -- See more on our front page news http://bit.ly/w28kSd #pfizer #astellas #prostatecancer #roche #elililly #diagnostics #medtech #alzheimers #atrialfibrillation #afib #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Alzheimer's Association campaigns for broader Leqembi coverage — FDA reverses course; will hold adcomm for Sarepta’s DMD gene therapy— Pfizer and Astellas report positive data from prostate cancer therapy trial -- See more on our front page news http://bit.ly/w28kSd #alzheimers #eisai #biogen #fda #dmd #duchenne #pfizer #astellas #clinicaltrials #prostatecancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023 — Astellas taps new CEO —Biogen and Sage get FDA priority review of depression med zuranolone -- See more on our front page news http://bit.ly/w28kSd #sanofi #earnings #druglaunches #astellas #ceos #biogen #sagetherapeutics #fda #depression #postpartumdepression #priorityreview #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort — AbbVie leaves PhRMA, BIO: reports —Astellas’ Phase III gastric cancer therapy trial meets primary endpoint -- See more on our front page news http://bit.ly/w28kSd #astrazeneca #patents #Symbicort #BIO #PhRMA #abbvie #astellas #clinicaltrials #gastriccancer #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma